Abstract:OBJECTIVE To investigate the anti-tumor effect of interventional chemotherapy with liposome doxorubicin for hepatic metastasis of pancreatic tumor in nude mice. METHODS After the establishment of hepatic metastatic model of pancreatic tumor, the nude mice received various formulations via a spleen injection to imitate the interventional chemotherapy. In each of two following experiments, 42 nude mice were randomly divided into 6 groups. They received liposomal doxorubicin (including high, intermittent and low-dose), free doxorubicin, gemcitabine plus cisplatin and control respectively. In the first experiment, the doses were 6, 3, 1.5, 3, 3 mg/kg and 100 µl 10% glucose for each group respectively. And in the second experiment, 9, 6, 3, 6, 6 mg/kg, and 100 µl 10% glucose respectively. The efficacies of interventional injection of liposomal doxorubicin with different doses were examined in terms of tumor growth retardation for the hepatic metastatic foci of pancreatic tumor. RESULTS In the first experiment, the difference of median hepatic tumor volume was significant among the three groups of mice receiving liposomal doxorubicin with incremental doses in a dose-dependent manner [high dose: (3 ± 1) mm(3), middle dose: (55 ± 18) mm(3), low dose: (90 ± 23) mm(3), P < 0.05]. The liposomal doxorubicin led to a substantial delay of tumor growth as compared to the free drug or gemcitabine plus cisplatin at the same dose (both P < 0.05). In addition, all animals were well-tolerated with no obvious acute toxicity. In the second experiment, significant difference was obtained for the mice injected with different doses of liposomal doxorubicin [(11 ± 4) mm(3), (13 ± 4) mm(3), (50 ± 18) mm(3), P < 0.05]. It was correlated with tumor growth delay. The mice administered with either 9 mg/kg or 6 mg/kg were more efficacious to retard tumor growth than those given 3 mg/kg (P < 0.05). Despite its enhanced effectiveness as compared to mice in gemcitabine plus cisplatin group (P < 0.05), the liposomal doxorubicin at a dose of 6 mg/kg resulted in a marginally delayed tumor growth compared to those of free doxorubicin at the same dose (P > 0.05). No evident acute toxic response was observed for each group of mice receiving liposomal doxorubicin. In contrast, approximately half of the animals receiving either free doxorubicin or gemcitabine plus cisplatin died of toxic responses. CONCLUSION Liposomal doxorubicin may be a potential interventional chemotherapeutic agent for hepatic metastasis of pancreatic tumor because of improved anti-tumor efficacy and reduced toxicity in comparison to free doxorubicin and gemcitabine plus cisplatin.

Study on the Antihepatocarcinoma Activity and the Acute Toxicity of Aclacimomycin-A Solid Lipids Nanoparticle for Injection in Mice in Vivo

The effect of histone deacetylase inhibitor ACY1215 on the inflammatory response in mice with acute liver failure

Toxicologic Evaluation of Repetitive 4-Week Intravenous Injections of Midkine Antisense Oligonucleotide Nanoliposomes in Rats

Preparation and Anti-Carcinoma Effect of Magnetic Polybutylcyanoacrylate Nanosphere Loaded with Aclacinomycin A

Liver Targeting and the Delayed Drug Release of the Nanoparticles of Adriamycin Polybutylcyanoacrylate in Mice

Inhibitive effect of Clinacanthus nutans (Burm.f.) Lindau n-butanol extracts on Heps hepatoma in mice

Inhibitory effect 131I-antiAFP McAb-DOX-BSA nanoparticles on hepatocellular carcinoma bearing nude mice

Preparation of Magnetic Polybutylcyanoacrylate Nanospheres Encapsulated with Aclacinomycin A and Its Effect on Gastric Tumor.

RGD-modified Liposomes Enhance Efficiency of Aclacinomycin A Delivery: Evaluation of Their Effect in Lung Cancer.

Anticancer effect and toxicity of brucine and brucine liposome in mice with transplant Heps tumors in vivo

Study on the effect of Shengmai Injection (生脉注射液) on the immune regulation of mice bearing hepatoma22 tumor

EXPERIMENTAL STUDY OF INTRATUMOR INJECTION WITH GELATIN MICROSPHERES CONTAINING 131 I AND MITOMYCIN C IN IMPLANTED HEPATOMA-22 IN MICE

Antitumor Effects of Paclitaxel-Loaded Liposome on S180 Solid-Tumour Bearing Mice in Vivo

Study on Synergic Effect of Shengmai Injection and Adriamycin

Experimental Study of Intratumor Injection of 90Y-Sag for the Treatment of Liver Cancer in Mice

Experimental Study on Anti-Tumor Efficacy of Shengmai Injection Combined with Oxaliplatin

Preparation and tissues distribution study of paclitaxel nanometric liposomes in mice

Antitumor Effect and Pharmacological Mechanism of Paclitaxel-loaded Silk Fibroin Nanomaterials on H22 Subcutaneous Tumor Model of Mouse Hepatoma

Percutaneous Intratumoral Injection of Traditional Chinese Herbal Compound Medicine Star-99 in Treatment of Hepatocellular Carcinoma of Mice

Putting together an MHC class I molecule.

[Anti-Tumor Efficacy of Interventional Chemotherapy with Liposomal Doxorubicin for Hepatic Metastasis of Pancreatic Cancer in Nude Mouse Model].